Gentamicin in the neonatal period.
D001724:Birth Weight; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects
D005839:Gentamicins; D010406:Penicillins; D007612:Kanamycin